| 研究生: |
鍾瑞玉 Chung, jui-yu |
|---|---|
| 論文名稱: |
4C架構下預防醫學自費診所的商業設計與客戶經營 Business Model and Customer Relationship Management of Self-Paid Preventive Medicine Clinics Within the 4C Framework |
| 指導教授: |
巫立宇
Wu, Lee-Yu 郭曉玲 Guo, Hsiao-Ling |
| 口試委員: |
王俊如
Wang, Chun-Ju 林宜霓 Lin, Yi-Ni 林智偉 Lin, Chih-Wei |
| 學位類別: |
碩士
Master |
| 系所名稱: |
商學院 - 經營管理碩士學程(EMBA) Executive Master of Business Administration(EMBA) |
| 論文出版年: | 2025 |
| 畢業學年度: | 114 |
| 語文別: | 中文 |
| 論文頁數: | 33 |
| 中文關鍵詞: | 預防醫學 、再生醫療 、4C策略架構 、相信品 、客戶終身價值 、分子點滴 、制度化信任 |
| 外文關鍵詞: | Preventive Medicine, Regenerative Medicine, 4C Strategic FrameworK, Credence Goods, Customer Lifetime Value, Molecular IV Drip, Institutionalized Trust |
| 相關次數: | 點閱:120 下載:0 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
本研究以邱志聖(2020)所提出的 4C 策略架構為理論基礎,探討在「相信品」(credence goods)屬性強烈的預防醫學市場中,自費診所如何透過制度化策略設計,建立可持續的顧客價值創造模型。研究以臺北市「美好健康診所」為單一個案,採質性研究方法,蒐集 2023 年至 2025 年間之實際經營資料與顧客行為數據,從 C1「外顯單位效益成本」、C2「資訊搜尋成本」、C3「道德危機成本」、C4「專屬陷入成本」四構面進行分析。
研究結果顯示,美好健康診所成功驗證 4C 架構於相信品市場中的優先順序:C3(信任成本)> C1(效益成本)> C4(陷入成本)> C2(搜尋成本)。其經營策略核心在於「制度化信任」之建立:以 3,500 元分子點滴作為低嘗試門檻(C1),導入 FAB 價值溝通重塑顧客感知;透過功能醫學檢測與醫師一對一解說降低資訊不對稱與信任風險(C2、C3);再以固定團隊、健康檔案與會員制度累積專屬資產(C4),形成「體驗—信任—升級—留存」之循環。
研究進一步指出,預防醫學診所的競爭力不在於療程或設備差異,而在於「信任生產機制」是否可被制度化、標準化與複製化。診所藉由標準化客戶旅程、統一價值語言及數據導向追蹤,使信任從「個人」轉為「組織」資產,達成年複購率 78%、顧客推薦率 32%之績效。最後,本研究提出三項建議:一、同業應以低門檻入場結合信任升級取代高單價推銷;二、診所應深化制度化信任機制與數位健康檔案系統;三、政策面應推動功能醫學檢測納入部分健保給付,促進全民健康壽命(Healhspan)之延長。
This study adopts Professor Chih-Sheng Chiu’s 4C strategic framework as its theoretical foundation to examine how self-pay preventive medicine clinics operating in a market characterized by strong credence-goods attributes can design institutionalized strategies to establish a sustainable customer value-creation model. Using “Mayhow Health Clinic,” located in Taipei, as a single-case study, the research employs qualitative methods and analyzes operational data and customer-behavior records collected between 2023 and 2025. The analysis is conducted across the four dimensions of the 4C framework: C1 “Cost of Observable Unit Benefits,” C2 “Information Search Costs,” C3 “Moral Hazard (Trust) Costs,” and C4 “Lock-in / Switching Costs.”
The findings reveal that Mayhow Health Clinic demonstrates the priority order of the 4C framework within credence-goods markets: C3 (trust cost) > C1 (benefit cost) > C4 (lock-in cost) > C2 (search cost). The core of its business strategy lies in establishing “institutionalized trust.” This is achieved by introducing a low-entry-barrier molecular IV drip priced at NT$3,500 (C1) and applying FAB-based value communication to reshape customers’ perceived value. The clinic further reduces information asymmetry and trust risks through functional-medicine testing and one-on-one physician consultations (C2, C3). Additionally, a fixed medical team, longitudinal health records, and a tiered membership program help accumulate exclusive customer assets (C4), forming a cycle of “Experience → Trust → Upgrade → Retention.”
The study further argues that the competitive advantage of preventive medicine clinics does not stem from differences in therapies or medical devices, but rather from whether their “trust-production mechanisms” can be institutionalized, standardized, and replicated. Through standardized customer journey design, unified value communication, and data-driven tracking, the clinic successfully transforms trust from an individual-level resource into an organizational asset, achieving an annual repurchase rate of 78% and a customer referral rate of 32%. Finally, this research proposes three recommendations: (1) industry practitioners should adopt low-entry, trust-building pathways rather than relying on high-priced sales tactics; (2) clinics should further enhance institutionalized trust mechanisms and invest in digital health-record systems; and (3) at the policy level, integrating functional-medicine diagnostics into partial National Health Insurance coverage would help promote an extension of national healthspan.
謝辭 I
摘要 II
Abstract III
目次 V
表次 VI
第一章 緒論 1
第一節 研究背景與動機 1
第二節 研究目的 3
第三節 研究範圍 4
第四節 研究流程 5
第二章 文獻探討 6
第一節 4C策略架構 6
第二節 4C策略在「相信品」市場之適用性 8
第三章 產業與個案 9
第一節 產業背景與自費醫療的經營挑戰 9
第二節 個案選擇理由 11
第四章 4C策略分析 13
第一節 C1策略:買者外顯單位效益成本的重塑 13
第二節 C2與C3策略:從資訊搜尋成本到道德危機成本的降低 15
第三節 C4策略:買者專屬陷入成本的累積 19
第五章 結論與建議 23
第一節 4C理論驗證與策略反思 23
第二節 研究發現 25
第三節 實務建議 28
第四節 研究限制與未來方向 30
參考文獻 33
立法院(2023)。《再生醫療法》與《再生醫療製劑條例》。
巫立宇、 邱志聖(2021),《銷售與顧客關係管理》(第二版),新陸書局
邱志聖(2020),《策略行銷分析:架構與實務應用》(第五版),智勝文化。
美好健康診所(2025)。《淺談預防醫學抗衰老》。內部簡報文件。
Yin, R. K. (2018). Case Study Research and Applications: Design and Methods (6th ed.). Sage Publications.
全文公開日期 2031/02/09